GATC Signs $3.2M DNA-Sequencing Contract with Medical Research Council | GenomeWeb

NEW YORK, May 26 (GenomeWeb News) - GATC Biotech today said it has signed a €2.5-million ($3.2 million) DNA-sequencing contract with the Medical Research Council.

According to the contract, GATC will provide the MRC's 35 sites in the United Kingdom with DNA sequencing services over a period of at least three years in return for about €2.5 million.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Nature this week: genome-wide transcriptome analysis of brain samples from people with autism spectrum disorder, flounder genome, and more.

Researchers used T-cell transfer therapy to target mutation KRAS, according to the New York Times.

The US Senate has passed the 21st Century Cures Act, which would provide a funding boost at NIH while overhauling FDA policies.

Bloomberg reports that President-elect Donald Trump is considering Jim O'Neill for Food and Drug Administration commissioner.